United States of America based
PharmaRen is a startup chemistry-based pharmaceutical company. Our focus is the design, synthesis and manufacturing of complex synthetic molecules for the injectable cytotoxic generic market. We are also developing a class of innovative, heparin-like drug candidates with the potential of effective treatments for cancers and central nervous system diseases.
TechnologiesPharmaceutical and Drug Discovery
No pipelines published yet
No services posted yet